SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-15-009699
Filing Date
2015-11-05
Accepted
2015-11-05 16:40:39
Documents
2
Period of Report
2015-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atra-8k_20151105.htm 8-K 26854
2 EX-99.1 ATARA BIOTHERAPEUTICS ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS atra-ex991_6.htm EX-99.1 281838
  Complete submission text file 0001564590-15-009699.txt   309866
Mailing Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 151201290
SIC: 2836 Biological Products, (No Diagnostic Substances)